Clearance marks SystImmune’s first IND enabled by pioneering New Approach Methodologies (NAMs), underscoring global innovation and translational leadership
SEOUL, South Korea, Sept. 22, 2026 /PRNewswire/ — AIMD Inc., a Korean medical technology company specializing in AI-powered emergency care, announced the global expansion of A-LRYNGO™, the world’s first AI-guided video laryngoscope with real-time automatic glottis recognition, as the company advances AI-guided airway management into clinical practice worldwide.
The first at-home urine test built to track stress patterns over time using a biological signal instead of a wearable estimate
AKRON, Ohio, Sept. 22, 2026 /PRNewswire/ — Resivant Medical announced today that the U.S. Patent and Trademark Office has issued Patent No. 12,678,148, covering the novel single-lever, single-handed applicator design at the core of the Cutiva™ PLUS Skin Closure System. The patent protects the mechanism that allows clinicians to start, control, and stop the flow of adhesive using a single lever, without repositioning the hand or device.
Pattern Bioscience, an Austin, Texas-based innovator in rapid diagnostic technologies for bacterial infections, has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its Urine ID/AST Panel. The panel is the company’s second assay to receive the designation, following the Pneumonia ID/AST Panel, reflecting Pattern’s continued focus on expanding a menu of rapid, direct-from-specimen assays.
Cordis earned FDA approval for its Selution SLR (sustained limus release) drug-eluting balloon (DEB) to treat coronary in-stent restenosis, the device developer announced today.
Johnson & Johnson MedTech’s DePuy Synthes Orthopaedics business launched its next-generation Maxframe Autostrut with Bluetooth Multi-Axial Correction System, the company announced today.
Cornell researchers have developed a portable diagnostic test that can simultaneously detect and distinguish Ebola and Lassa.
Tumors require a blood supply to grow and survive. The blood vessels that nourish tumors can have different characteristics across cancer types and could be connected to patient survival and outcomes. Researchers from Mass General Brigham Cancer Institute, the Broad Institute of MIT and Harvard, and Harvard T.H. Chan School of Public Health conducted a prospective cohort study using advanced imaging techniques to microscopically characterize colorectal tumor vessels.
Bone marrow transplants offer an unexpected way for diseased cells in the heart and brain to get replacement parts, a Stanford Medicine-led study has shown. The finding offers hope for the first effective treatment of mitochondrial disorders, a group of genetic diseases in which cells’ motors, called mitochondria, are dysfunctional.